Sign Up to like & get
recommendations!
2
Published in 2022 at "European journal of heart failure"
DOI: 10.1002/ejhf.2675
Abstract: The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to the high costs of conducting large randomized clinical trials that are needed to adequately power major…
read more here.
Keywords:
biomarkers working;
heart failure;
working group;
review biomarkers ... See more keywords